Literature DB >> 22580786

Circulating and urinary microRNAs in kidney disease.

Johan M Lorenzen1, Thomas Thum.   

Abstract

microRNAs are small, noncoding RNAs that control gene/protein expression through target messengerRNA degradation and/or inhibition of protein synthesis. An array of experimental studies has shown the importance of microRNAs for disease initiation/progression. microRNAs are generally considered to act as intracellular modulators of gene expression. However, first studies in the cancer and cardiovascular field have elucidated that microRNAs are remarkably stable in the extracellular compartment (e.g., in blood or urine). The detection and quantification of circulating microRNAs may, thus, represent a novel noninvasive tool to detect and monitor disease activity. In addition, there might be a potential biologic relevance of circulating microRNAs for cell/cell communication. The aim of the present article is to give an outline of recent work on circulating and urinary microRNAs as well as their potential paracrine activity in kidney disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22580786     DOI: 10.2215/CJN.01170212

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  35 in total

1.  Identification of novel circulatory microRNA signatures linked to patients with ischemic stroke.

Authors:  Murali Vijayan; Subodh Kumar; Xiangling Yin; Dila Zafer; Vishal Chanana; Pelin Cengiz; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2018-07-01       Impact factor: 6.150

2.  Influence of peripheral whole-blood microRNA-7 and microRNA-221 high expression levels on the acquisition of castration-resistant prostate cancer: evidences from in vitro and in vivo studies.

Authors:  Juliana I Santos; Ana L Teixeira; Francisca Dias; Joaquina Maurício; Francisco Lobo; António Morais; Rui Medeiros
Journal:  Tumour Biol       Date:  2014-04-24

3.  A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinoma.

Authors:  Yu-Zheng Ge; Ran Wu; Hui Xin; Meng Zhu; Tian-Ze Lu; Hao Liu; Zheng Xu; Peng Yu; You-Cai Zhao; Ming-Hao Li; Zhi-Kai Hu; Yan Zhao; Bing Zhong; Xiao Xu; Liu-Hua Zhou; Lu-Wei Xu; Jian-Ping Wu; Wen-Cheng Li; Jia-Geng Zhu; Rui-Peng Jia
Journal:  J Cancer Res Clin Oncol       Date:  2015-01-30       Impact factor: 4.553

Review 4.  Regulatory pathways for ATP-binding cassette transport proteins in kidney proximal tubules.

Authors:  Rosalinde Masereeuw; Frans G M Russel
Journal:  AAPS J       Date:  2012-09-08       Impact factor: 4.009

Review 5.  The ureteric bud epithelium: morphogenesis and roles in metanephric kidney patterning.

Authors:  Vidya K Nagalakshmi; Jing Yu
Journal:  Mol Reprod Dev       Date:  2015-03-17       Impact factor: 2.609

Review 6.  [Non-coding RNA : Innovative regulators with therapeutic perspective].

Authors:  A Bührke; C Bär; T Thum
Journal:  Herz       Date:  2018-03       Impact factor: 1.443

Review 7.  MicroRNAs in kidney physiology and disease.

Authors:  Piera Trionfini; Ariela Benigni; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2014-11-11       Impact factor: 28.314

8.  High Glucose Induces Mesangial Cell Apoptosis through miR-15b-5p and Promotes Diabetic Nephropathy by Extracellular Vesicle Delivery.

Authors:  Yi-Chun Tsai; Mei-Chuan Kuo; Wei-Wen Hung; Ling-Yu Wu; Ping-Hsun Wu; Wei-An Chang; Po-Lin Kuo; Ya-Ling Hsu
Journal:  Mol Ther       Date:  2020-01-15       Impact factor: 11.454

Review 9.  Epigenetics: a potential key mechanism involved in the pathogenesis of cardiorenal syndromes.

Authors:  Grazia Maria Virzì; Anna Clementi; Alessandra Brocca; Massimo de Cal; Claudio Ronco
Journal:  J Nephrol       Date:  2017-08-05       Impact factor: 3.902

10.  A microarray analysis of urinary microRNAs in renal diseases.

Authors:  Tsuneo Konta; Kazunobu Ichikawa; Kazuko Suzuki; Kosuke Kudo; Hiroko Satoh; Keita Kamei; Emiko Nishidate; Isao Kubota
Journal:  Clin Exp Nephrol       Date:  2013-11-06       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.